https://www.roche.com/investors/updates/inv-update-2017-09-18
Phase III data showed that Venclexta/Venclyxto plus MabThera/Rituxan helped people with previously...
Roche announced today that the phase III MURANO study, which evaluated Venclexta®/Venclyxto® (venetoclax) in combination with MabThera®/Rituxan® (rituximab) in...
phase iiidatashowedvenclextavenclyxto